Updated: Sep 18
Medically reviewed by ChinaCureLink Team
Table of Content
Why This Case Matters
This case involves a 55-year-old Chinese woman with invasive ductal carcinoma of the breast and multiple lymph node metastases who eventually received breast cancer cryoablation in China. Her experience illustrates why timely diagnosis and specialist assessment matter when a breast lump changes or continues to grow.
For international patients exploring minimally invasive cancer treatment in China, ChinaCureLink can help arrange a medical case review, identify an appropriate specialist center, and coordinate the practical steps involved in seeking treatment abroad.
Key Takeaways |
|
Patient Background
The patient first experienced breast swelling and pain in May 2021. She noticed a firm lump in her breast that was approximately the size of a peanut.
An ultrasound examination at a local maternal and child health hospital identified breast nodules. She then traveled to Shanghai for further evaluation.
Pathological biopsy and immunohistochemistry indicated invasive ductal carcinoma, and doctors recommended surgery.
Instead of proceeding directly with the recommended treatment, she initially chose an alternative approach at home. She used self-medication, breast massage, and a self-imposed dietary restriction.
Over time, the breast lump grew significantly. The breast became red and painful, and she developed pain in her left upper arm. Further assessment also identified multiple lymph node metastases in both axillae.
At this stage, she was introduced to a licensed oncology hospital in Guangzhou, China, by another patient and proceeded with standardized diagnosis and treatment.
The Care Team and Approach
The treatment approach centered on cryoablation, a minimally invasive tumor-ablation technique that uses extremely low temperatures to freeze and destroy targeted tumor tissue.
Argon-helium cryoablation uses a specialized probe rather than a conventional surgical knife. Rapid cooling creates an ice zone within the targeted tissue, while subsequent warming contributes to cellular destruction. The technique is designed to allow physicians to define the treatment area while minimizing disruption to surrounding tissue.
The hospital describes cryoablation as one of its minimally invasive treatment techniques for solid tumors, including breast cancer.
For this patient, cryoablation was used after her breast cancer had progressed and lymph node metastases had developed. The case demonstrates the use of a minimally invasive local treatment approach in a patient whose disease had become more extensive after the initial diagnosis.
Treatment Timeline/ Process
Initial Diagnosis
May 2021: Developed breast swelling and pain.
Noticed a small, firm lump approximately the size of a peanut.
Ultrasound at a local maternal and child health hospital identified breast nodules.
Further assessment in Shanghai included pathological biopsy and immunohistochemistry.
The findings indicated invasive ductal carcinoma, and surgery was recommended.
Disease Progression
Choose self-treatment rather than proceeding immediately with the recommended surgery.
Used self-medication, massage, and dietary restriction.
The breast lump subsequently became significantly larger.
Developed breast redness and pain.
Developed pain in the left upper arm.
Multiple lymph node metastases were identified in both axillae.
Cryoablation Treatment in China
Was introduced to a licensed oncology hospital in Guangzhou, China, by another patient.
Proceeded with standardized diagnosis and treatment.
Received cryoablation for the breast tumor.
Following treatment, the tumor tissue had largely necrotized.
Outcome
Following breast cancer cryoablation, the tumor tissue had largely necrotized, and the patient's condition was reported as under control.
The case does not provide evidence of complete remission or cure, so the outcome should be described in terms of tumor necrosis and disease control rather than remission.
It also highlights an important distinction: cryoablation is a treatment technique that may be considered in selected cancer cases, but it is not appropriate for every breast cancer patient. Treatment decisions depend on the individual diagnosis, tumor characteristics, disease extent, previous treatment, and overall health.
How ChinaCureLink Can Help International Patients to Access This Treatment
International patients interested in breast cancer cryoablation in China can begin with a medical case review rather than traveling before their eligibility and treatment options have been assessed.
ChinaCureLink can help coordinate the process by collecting medical records and imaging, arranging translation where needed, identifying an appropriate specialist hospital, and coordinating an online consultation before travel.
For patients with breast cancer that has progressed or who are exploring minimally invasive treatment options, the first step is a specialist assessment of the complete medical history and current disease status. The treating team can then determine whether cryoablation or another treatment approach is clinically appropriate.
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
★★★★☆ Sarah Zhang · Canada· Jul 2024 · Verified “The interpreter during the video call was fantastic — super professional and answered all our questions clearly and quickly. The professor was also very patient and gave us detailed and honest guidance on our treatment options.” |
★★★★★ Andrew Goh · Singapore · Aug 2024 · Verified “My first contact with Medebound was over a year ago. Jason has always been responsive, even when I wasn't ready to proceed. When I finally did, the consultation was seamlessly arranged and the specialist was outstanding.” |
★★★★★ Daniel Wong · Singapore · Aug 2024 · Verified “I have dry eye and nothing seemed to be working, even with different medications. I heard about a medication from the U.S. that’s supposed to be really effective, but I didn’t want to try it without talking to a doctor first. MEDEBOUND connected me with a top ophthalmologist in the U.S. and it was so reassuring to get their expert advice.” |
★★★★☆ Pongsakorn · Thailand · Feb 2025 · Verified “Kiki at Medebound is amazing — so professional and helpful! They got my video consultation with an MD Anderson expert set up super fast, within just 5 working days. I am so grateful for their support.” |
Frequently Asked Questions
Is breast cancer cryoablation suitable for patients with lymph node metastases?
Suitability depends on the individual case. The presence, location, and extent of lymph node metastases must be evaluated alongside the primary breast tumor, previous treatments, imaging, pathology, and overall health. A specialist assessment is required before determining whether cryoablation is appropriate.
How can an international patient access breast cancer cryoablation in China?
International patients can begin by submitting pathology reports, imaging, treatment history, and other relevant medical records for specialist review. ChinaCureLink can help coordinate medical record translation, hospital matching, specialist consultation, treatment scheduling, and travel-related logistics.
How much does breast cancer cryoablation cost in China?
The cost depends on the patient's diagnosis, tumor characteristics, treatment plan, hospital, and any additional diagnostic or supportive care required. A case-specific estimate should be obtained after the medical team reviews the patient's records and determines the appropriate treatment plan.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This account reflects one patient's individual experience, which will vary by case, diagnosis stage, and other clinical factors. ChinaCureLink facilitates access to hospitals and treatment coordination — we do not provide medical care ourselves, and this content is not medical advice. Patients and families should consult a qualified oncologist before making treatment decisions.